Skip to main navigation
Skip to search
Skip to main content

Mayo Clinic Home

Home
Profiles
Departments/Divisions
Grants
Research output
Prizes

Search by expertise, name or affiliation

Upfront low-dose ponatinib (15 mg/day) for multi-TKI resistant chronic myeloid leukemia

Hematology

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Upfront low-dose ponatinib (15 mg/day) for multi-TKI resistant chronic myeloid leukemia'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility

Report vulnerability